Document is current
Any future updates will be listed below
-
Authors
Viehweger, Florian
Böcker, Carola
Weidemann, Sören
Freytag, Morton
Menz, Anne
Büscheck, Franziska
Luebke, Andreas M.
Putri, Devita
Kluth, Martina
Hube-Magg, Claudia
Hinsch, Andrea
Lennartz, Maximilian
Lutz, Florian
Reiswich, Viktor
Höflmayer, Doris
Fraune, Christoph
Möller, Katharina
Bernreuther, Christian
Lebok, Patrick
Sauter, Guido
Steurer, Stefan
Dum, David
Marx, Andreas H.
Simon, Ronald
Krech, Till
Clauditz, Till S.
Jacobsen, Frank
Gorbokon, Natalia
Burandt, Eike
Minner, Sarah
Kind, Simon
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 3 November 2023
Accepted: 21 December 2023
First Online: 13 January 2024
Declarations
:
: The use of archived remnants of diagnostic tissues for manufacturing of TMAs and their analysis for research purposes as well as patient data analysis has been approved by local laws (HmbKHG, § 12) and by the local ethics committee (Ethics commission Hamburg, WF-049/09). All work has been carried out in compliance with the Helsinki Declaration.
: Not required.
: The rabbit recombinant prostein-antibody, clone MSVA-460R was provided from MS Validated Antibodies GmbH (owned by a family member of GS).
